跳至主要内容
临床试验/EUCTR2004-000623-16-GB
EUCTR2004-000623-16-GB进行中(未招募)不适用

A retrospective study to compare the 3-year antiviral efficacy of nevirapine and efavirenz in combination with D4T and 3TC in 2NN patients - 2NN Follow-up study

Boehringer Ingelheim Ltd0 个研究点目标入组 750 人开始时间: 2005年2月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Participation in the initial 2NN study (protocol 1100.1288)
  • 2. Under active follow-up at the end of the initial 2NN study (i.e. at week 48), whether or not using randomized treatment.
  • 3. Ability and willingness to give written informed consent.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 未提供

研究者

相似试验

进行中(未招募)
1 期
A retrospective study to compare the 3-year antiviral efficacy of nevirapine and efavirenz in combination with D4T and 3TC in 2NN patients - 2NN Follow-up studyTreatment of HIV-1 infection
EUCTR2004-000623-16-BEn.v. Boehringer Ingelheim s.a.750
已完成
不适用
BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada
PER-080-05BRISTOL MYERS SQUIBB COMPANY,
进行中(未招募)
1 期
A 3-Year Follow-up Study in Subjects previously treated with Odalasvir and AL-335 With or Without Simeprevir for Hepatitis C Virus (HCV) Infection.
EUCTR2016-002608-19-PLJanssen-Cilag International NV54
进行中(未招募)
1 期
A 3-Year Follow-up Study in Subjects previously treated with Odalasvir and AL-335 With or Without Simeprevir for Hepatitis C Virus (HCV) Infection.Chronic Hepatitis C virus infection.MedDRA version: 19.1 Level: PT Classification code 10019744 Term: Hepatitis C System Organ Class: 10021881 - Infections and infestations
EUCTR2016-002608-19-DEJanssen-Cilag International NV54
进行中(未招募)
1 期
A 3-Year Follow-up Study in Subjects previously treated with Odalasvir and AL-335 With or Without Simeprevir for Hepatitis C Virus (HCV) Infection.Chronic Hepatitis C virus infection.MedDRA version: 19.1Level: PTClassification code 10019744Term: Hepatitis CSystem Organ Class: 10021881 - Infections and infestations
EUCTR2016-002608-19-ESJanssen-Cilag International NV250